French biotech snags vaccine grant; Novavax rises on early RSV data;

> French biotech Imaxio and its partners have won a grant to develop a Staphylococcus aureus vaccine. Release (pdf)

> Positive results from an early-phase respiratory virus vaccine trial pushed Novavax ($NVAX) shares higher. News

> Indian firm Biological E has won a $200 million deal to supply pentavalent vaccines to Egypt. Article

> A genital herpes vaccine is advancing toward clinical trials. Piece

> Indian regulators continue to investigate the relabeling of vaccines by Panacea Biotec. Item

> A malaria vaccine is tipped to enter clinical trials after impressing in mice. Study